Heme oxygenase and its role in defense system; Paradigm shift of anti-inflammatory therapy

Japanese Journal of Clinical Immunology

Volumn 30, Issue 1, 2007, Pages 11-21

  Yachie, Akihiro ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

Author keywords

Heme oxygenase 1; Inflammation; Monocyte; Oxidative stress; Regulatory T cell

Indexed keywords

HEME OXYGENASE;

BIOSYNTHESIS; HUMAN; INFLAMMATION; MONOCYTE; PHYSIOLOGY; REVIEW;

HEME OXYGENASE (DECYCLIZING); HUMANS; INFLAMMATION; MONOCYTES;

EID: 34247880412     PISSN: 09114300     EISSN: 13497413     Source Type: Journal    
DOI: 10.2177/jsci.30.11     Document Type: Article

References (54)

1. Akira, S. and Takeda, K.: Toll-like receptor signaling. Nat. Rev. Immunol. 4: 499–511, 2004.
2. Ulevitch, R. J.: Therapeutics targeting the innate immune system. Nat. Rev. Immunol. 4: 512–520, 2004.
3. Ehlers, M., Ravetch, J. V.: Opposing effects of Toll-like receptor stimulation induce autoimmunity or tolerance. Trends. Immunol. 2006 in press.
4. Jiang, H., Chess, L.: Regulation of immune responses by T cells. N. Engl. J. Med. 354: 1166–1176, 2006.
5. Ziegler, S. F.: FOXP3: Of mice and men. Annu. Rev. Immunol. 24: 7.1–7.18, 2006.
6. Levings, M. K., et al.: Functional dynamics of naturally occurring regulatory T cells in health and autoimmunity. Adv. Immunol. 92: 119–155, 2006.
7. Müllauer, L., et al.: Mutations in apoptosis genes: A pathogenetic factor for human disease. Mut. Res. 488: 211–231, 2001.
8. Su, M. A. and Anderson, M. S.: Aire: An update. Curr. Opin. Immunol. 16: 746–752, 2004.
9. Kastner, D. L. and O’Shea, J. J.: A fever gene comes in from cold. Nat. Genet. 29: 241–242, 2001.
10. Inohara, N. and Nunez, G.: NODS: Intracellular proteins involved in inflammation and apoptosis. Nat. Rev. Immunol. 3: 371–382, 2003.
11. Tschopp, J., Martinon, F. and Burns, K.: NALPS: A novel protein family involved in inflammation. Nat. Rev. Mol. Cell. Biol. 4: 95–104, 2003.
12. Murray, P. J.: NOD proteins: An intracellular pathogen-recognition system or signal transduction modifiers? Curr. Opin. Immunol. 17: 352–358, 2005.
13. Ogura, Y., Sutterwala, F. S. and Flavell, R. A.: The inlammasome: First line of the immune response to cell stress. Cell 126: 659–662, 2006.
14. Mariathasan, S. and Monack, D. M.: Inlammasome adaptors and sensors: Intracellular regulators of infection and inlammation. Nat. Rev. Immunol. 7: 31–40, 2007.
15. Yachie, A., et al.: Oxidative stress caused enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J. Clin. Invest. 103: 129–135, 1999.
16. Maines, M. D.: Heme oxygenase: Function, multiplicity, regulatory mechanism, and clinical applications. FASEB. J. 2: 2557–2568, 1988.
17. Maines, M. D.: The heme oxygenase system: A regulator of second messenger gases. Annu. Rev. Pharmacol. Toxicol. 37: 517–554, 1997.
18. Okinaga, S., et al.: Regulation of human heme oxygenase-1 gene expression under thermal stress. Blood 87: 5074–5084, 1996.
19. Cantoni, L., et al.: Interleukin-1and tumor necrosis factor induce hepatic haeme oxygenase. Biochem. J. 279: 891–894, 1991.
20. Yachie, A., et al.: Human HO-1 deficiency and the oxidative injury of vascular endothelial cells. Abraham, N. G., eds. Heme oxygenase in biology and medicine. Kluwer Academic/Plenum Publishers, New York, 325–341, 2002.
21. Kawashima, A., et al.: Heme oxygenase-1 deiciency: The irst autopsy case. Hum. Pathol. 33: 125–130, 2002.
22. Poss, K. D. and Tonegawa, S.: Heme oxygenase 1 is required for mammalian iron reutilization. Proc. Natl. Acad. Sci. USA. 94: 10919–10924, 1997.
23. Poss, K. D. and Tonegawa, S.: Reduced stress defenseinhemeoxygenase1-deicient cells. Proc.Natl. Acad. Sci. USA. 94: 10925–10930, 1997.
24. Morimoto, K., et al.: Cytoprotective role of heme oxygenase (HO) -1 in human kidney with various renal diseases. Kidney Int. 60: 1868–2866, 2001.
25. Shimizu, M., et al.: Glomerular proteinuria induces heme oxygenase-1 gene expression within renal epithelial cells. Pediatr. Res. 58: 666–671, 2005.
26. Yang, Y., et al.: Selective protection of renal tubular epithelial cells by heme oxygenase (HO)-1 during stress-induced injury. Kidney Int. 64: 1302–1309, 2003.
27. Ohta, K., et al.: Tubular injury as a cardinal pathologic feature in human heme oxygenase-1 deiciency. Am. J. Kidney Dis. 35: 863–870, 2000.
28. Yachie, A., et al.: Heme oxygenase-1 production by peripheral blood monocytes during acute inflammatory illnesses of children. Exp. Biol. Med. 228: 550–556, 2003.
29. Goda, N., et al.: Distribution of heme oxygenase isoforms in rat liver. Topographic basis for carbon monoxide-mediated microvascular relaxation. J. Clin. Invest. 101: 604–612, 1998.
30. Kristiansen, M., et al.: Identiication of the haemoglobin scavenger receptor. Nature 409: 198–201, 2001.
31. Willis, D., et al.: Heme oxygenase: A novel target for the modulation of the inlammatory response. Nat. Med. 2: 87–90, 1996.
32. Ryster, S. W., Morse, D. and Choi, A. M.: Carbon monoxide and bilirubin: Potential therapies for pulmonary/vascular injury and disease. Am. J. Respir. Cell. Mol. Biol.2006 in press.
33. Li, Y. X., et al.: Protection of human islets from induction of apoptosis and improved islet function with HO-1 gene transduction. Chin. Med. J. 119: 1639–1645, 2006.
34. Liu, X., et al.: Hemeoxygenase-1 (HO-1) inhibits postmyocardial infarct remodeling and restores ventricular function. FASEB. J. 20: 207–216, 2006.
35. Shinohara, T., et al.: Adenovirus-mediated transfer and overexpression of heme oxygenase 1 cDNA in lungs attenuates elastase-induced pulmonary emphysema in mice. Hum. Gene. Ther. 16: 318–327, 2005.
36. Abraham, N.G. and Kappas, A.: Heme oxygenase and the cardiovascular-renal system. Free Radical Biol. Med. 39: 1–25, 2005.
37. Yachie, A., et al.: Human HO-1 deficiency and cardiovascular dysfunction. Wang, R., eds. Carbon monoxide and cardiovascular functions. CRC Press, Boca Raton, 181–212, 2002.
38. Maruhashi, K., et al.: Paradoxical enhancement of oxidative cell injury by overexpression of heme oxygenase-1 in an anchorage-dependent cell ECV304. J. Cell. Biochem. 93: 552–562, 2004.
39. Frankenberger, M., et al.: Differential cytokine expression in human blood monocyte subpopulations.: A polymerase chain reaction analysis. Blood 87: 373–377, 1996.
40. Katayama, K., et al.: CD14+ CD16+ monocyte subpopulation in Kawasaki disease. Clin. Exp. Immunol. 121: 566–570, 2000.
41. + monocytes in human sepsis: A case report of a patient with self-induced septicemia. Shock 8: 73–75, 1997.
42. Kawanaka, N., et al.: CD14+ CD16+ blood monocytes and joint inlammation in rheumatoid arthritis. Arthritis Rheum. 46: 2578–2586, 2002.
43. Geissman, F., et al.: Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19: 71–82, 2003.
44. − subpopulation of circulating monocytes with preferential production of haem oxygenase (HO)-1 in response to acute inlammation. Clin. Exp. Immunol. 142: 461–470, 2005.
45. Philippidis, P. et al.: Hemoglobin scanvenger receptor CD163 mediates interleukin-10 release and heme oxygenase-1 synthesis. Antiinlammatory monocye-macrophage responses in vitro, in resolving skin blisters in vivo, andafter cardiopulmonary bypass surgery. Circ. Res. 94: 119–126, 2004.
46. Abraham, M. G. and Drummond, G.: CD163-mediated hemoglobin-heme uptake activates macrophage HO-1, providing an anti-inlammatory function. Circ. Res. 99: 911–914, 2006.
47. Soares, M. P., et al.: Expression of heme oxygenase-1 can determine cardiac xenograft survival. Nat. Med. 4: 1073–1077, 1998.
48. Yamashita, K., et al.: Biliverdin, a natural product of heme catabolism, induces tolerance to cardiac allografts. FASEB. J. 18: 765–767, 2004.
49. Bach, F.H.: Hemeoxygenase-1 and transplantation tolerance. Hum. Immunol. 67: 430–432, 2006.
50. Yamashita, K., et al.: Heme oxygenase-1is essential for and promotes tolerance to transplanted organs. FASEB. J. 20: 776–778, 2006.
51. Gerbitz, A., et al.: Induction of heme oxygenase-1 before conditioning results in improved survival and reduced graft-versus-host disease after experimental allogeneic bone marrow transplantation. Biol. Blood Marrow Transplant. 10: 461–472, 2004.
52. Hess, A. D.: Modulation of graft-versus-host disease: Role of regulatory T lymphocytes. Biol. Blood Marrow Transplant. 12: 13–22, 2006.
53. Zorn, E.: CD4+ CD25+ regulatory T cells in human hematopoietic cell transplantation. Semin. Cancer Biol. 16: 150–159, 2006.
54. Barrett, J.: Improving outcome of allogeneic stem cell transplantation by immunomodulation of the early post-transplant environment. Curr. Opin. Immunol. 18: 592–598, 2006.